Changes in recreational drug use, reasons for those changes and their consequence during and after the COVID-19 pandemic in the UK

作者：Maria Bălăeţ, Ana Zadel, Anne Lingford‐Hughes, Louise M. Paterson, Samuel R. Chamberlain, William Trender, Peter J. Hellyer, Adam Hampshire · 发表于：Comprehensive Psychiatry · 年份：2025 · DOI：10.1016/j.comppsych.2025.152598 · 被引用次数：4 · 研究领域：Opioid Use Disorder Treatment、COVID-19 and Mental Health、COVID-19 Clinical Research Studies

Changes in drug use in the general population during the COVID-19 pandemic and their long-term consequences are not well understood. We employed natural language processing and machine learning to analyse a large dataset of self-reported rates of and reasons for drug use during the pandemic, along with their associations with anxiety, depression and substance use problems post-pandemic. Our findings revealed a transient decrease in drug use at the pandemic's peak, primarily attributed to reduced social opportunities. Conversely, some participants reported increased drug use for self-medication, boredom, and lifestyle disruptions. While users of psychedelics and MDMA had anxiety and depression rates similar to non-users, users of opioid agonists and depressants-representing one in ten active drug users-reported greater mental health challenges post-pandemic. These results suggest that a subset of active drug users with distinct profiles faces elevated risks, particularly for anxiety and depression, and may benefit from targeted support.